MarketCap
Facebook
X
Telegram
Applied Molecular Transport EV | AMTI
EV Jährlich Applied Molecular Transport
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.6 M | 138 M | 1.12 B | -8.11 M | 47.1 M | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.12 B | -8.11 M | 261 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Prothena Corporation plc
PRTA
|
-10.4 M | $ 8.74 | 2.1 % | $ 470 M |  USA |
 |
Exelixis
EXEL
|
11.9 B | $ 70.73 | 0.21 % | $ 19.2 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | USA |
 |
Фармсинтез
LIFE
|
59.3 B | - | - | - |  Russia |
 |
Arcus Biosciences
RCUS
|
1.95 B | $ 18.83 | 0.86 % | $ 2.02 B | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
153 B | $ 14.79 | -0.57 % | $ 12.3 B |  India |
 |
Oncternal Therapeutics
ONCT
|
27.3 M | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
52.5 M | - | - | $ 591 K |  Irlanda |
 |
Royalty Pharma plc
RPRX
|
28.2 B | $ 70.01 | 0.81 % | $ 30.1 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
6.5 B | $ 114.06 | 0.1 % | $ 7.41 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
4.35 M | - | - | $ 26.5 M | USA |
 |
SIGA Technologies
SIGA
|
270 M | $ 3.17 | 0.32 % | $ 227 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
15.7 M | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
935 M | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
-6.87 M | - | -8.77 % | $ 12.4 M |  Israel |
 |
Histogen
HSTO
|
-3.2 M | - | 31.6 % | $ 2.12 M | USA |
 |
Summit Therapeutics
SMMT
|
11.9 B | $ 16.64 | -6.7 % | $ 12.4 B |  Britain |
 |
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | USA |
 |
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | USA |
 |
Syndax Pharmaceuticals
SNDX
|
2.06 B | $ 9.59 | 1.05 % | $ 831 M | USA |
 |
Scholar Rock Holding Corporation
SRRK
|
4.92 B | $ 46.66 | -2.8 % | $ 5.35 B | USA |
 |
Clovis Oncology
CLVS
|
870 M | - | -7.23 % | $ 13 M | USA |
|
Protara Therapeutics
TARA
|
208 M | $ 2.61 | 7.41 % | $ 112 M | USA |
 |
Tarsus Pharmaceuticals
TARS
|
2.95 B | $ 76.79 | 4.0 % | $ 3.21 B | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
250 M | - | - | $ 1.62 B | Israel |
 |
Bio-Techne Corporation
TECH
|
11 B | $ 72.8 | -0.03 % | $ 11.4 B | USA |
 |
Cabaletta Bio
CABA
|
253 M | $ 1.46 | 0.69 % | $ 147 M | USA |
 |
Gilead Sciences
GILD
|
176 B | $ 169.72 | -0.67 % | $ 211 B | USA |
 |
PhaseBio Pharmaceuticals
PHAS
|
226 M | - | 7.4 % | $ 6.29 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
452 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
6.74 B | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
22.9 B | - | - | $ 26.6 B | Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-61.5 M | $ 3.86 | -5.98 % | $ 32.9 M | USA |
 |
Gossamer Bio
GOSS
|
365 M | $ 11.6 | 2.84 % | $ 2.65 B | USA |
 |
Provention Bio
PRVB
|
1.86 B | - | - | $ 2.37 B | USA |
 |
DBV Technologies S.A.
DBVT
|
2.69 B | $ 11.85 | 2.95 % | $ 1.65 B |  France |
 |
Taysha Gene Therapies
TSHA
|
1.23 B | $ 4.26 | -0.35 % | $ 1.36 B | USA |
 |
Reata Pharmaceuticals
RETA
|
1.6 B | - | - | $ 6.29 B | USA |
 |
iTeos Therapeutics
ITOS
|
248 M | - | - | $ 411 M | USA |
 |
PolarityTE
PTE
|
-900 K | - | -0.82 % | $ 1.78 M | USA |
 |
Kronos Bio
KRON
|
-47.8 M | - | 1.49 % | $ 50.8 M | USA |
 |
United Therapeutics Corporation
UTHR
|
22.8 B | $ 595.86 | 1.23 % | $ 26.4 B | USA |
 |
Landos Biopharma
LABP
|
16.9 M | - | 0.58 % | $ 144 M | USA |
 |
Vericel Corporation
VCEL
|
1.92 B | $ 59.45 | 0.7 % | $ 2.99 B | USA |
 |
Veracyte
VCYT
|
2.78 B | $ 25.08 | 4.24 % | $ 1.97 B | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Viking Therapeutics
VKTX
|
3.09 B | $ 28.63 | -0.1 % | $ 3.23 B | USA |
 |
vTv Therapeutics
VTVT
|
-63.5 M | $ 21.72 | 3.4 % | $ 87.1 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-2.04 M | $ 3.62 | -5.97 % | $ 1.6 M | USA |
 |
Trevena
TRVN
|
20.4 M | - | -46.58 % | $ 31.8 M | USA |